InsiderTrades

Form 4 for TTD Trade Desk (The)

Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-14 · accession 0001671933-25-000023 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-02-19 2025-02-14 TTD Kayyal Alex Dir A - Grant $4.36 +1,577 1,202 New +$6,871
DM 2025-02-19 2025-02-14 TTD Kayyal Alex Dir A - Grant $2.06 +3,382 2,576 New +$6,977

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-02-14 A A 57 $120.54 1,577 D — — (F4) The restricted stock units will vest in full on May 28, 2025 or, if earlier, the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. (F6) This price represents the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of restricted stock units granted. (F7) These restricted stock units were issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $25,000, prorated from the date of grant to the date of the Issuer's next annual meeting of stockholders.
2 Common Class A Common Stock 2025-02-14 A A 318 $0.00 1,520 D — — (F4) The restricted stock units will vest in full on May 28, 2025 or, if earlier, the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. (F5) These restricted stock units were issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant prorated from the date of grant to the date of the Issuer's next annual meeting of stockholders.
3 Common Class A Common Stock 2025-02-14 A A 1,202 $0.00 1,202 D — — (F2) The restricted stock units vest in quarterly installments over the three-year period following the grant, subject to the Reporting Person's continuous service as a member of the board of directors through such date. (F3) These restricted stock units were issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an initial director equity grant.
4 Derivative Stock Option (Right to Buy) 2025-02-14 A A 682 $0.00 3,258 D $80.16 · — to 2035-02-14 682 Class A Common Stock (F12) This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant prorated from the date of grant to the date of the Issuer's next annual meeting of stockholders. (F11) The shares subject to the option vest in full on May 28, 2025 or, if earlier, the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
5 Derivative Stock Option (Right to Buy) 2025-02-14 A A 124 $56.27 3,382 D $80.16 · — to 2035-02-14 124 Class A Common Stock (F13) This price represents the Black-Scholes value of an option using the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of shares subject to the option granted. (F14) These stock options were issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $25,000, prorated from the date of grant to the date of the Issuer's next annual meeting of stockholders. (F11) The shares subject to the option vest in full on May 28, 2025 or, if earlier, the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
6 Derivative Stock Option (Right to Buy) 2025-02-14 A A 2,576 $0.00 2,576 D $80.16 · — to 2035-02-14 2,576 Class A Common Stock (F10) This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an initial director equity grant. (F9) The shares subject to the option vest in quarterly installments over the three-year period following the grant, subject to the Reporting Person's continuous service as a member of the board of directors through such date.